Selangor Journal
A vaccinator prepares a syringe containing the Covid-19 vaccine during the Selangor Vaccination Programme (Selvax) at the De Palma Hotel vaccination centre, Shah Alam, on August 19, 2021. — Picture by AHMAD ZAKKI JILAN/SELANGORKINI

Malaysia in midst of developing methods to administer vaccine orally, using nasal spray

KUALA LUMPUR, March 7 — Malaysia through the National Vaccine Development Roadmap (PPVN) is developing methods to administer the Covid-19 vaccine orally or using nasal spray, said Science, Technology and Innovation Deputy Minister Datuk Ahmad Amzad Hashim.

He said the different methods of administering the vaccine were being studied because there were people who were afraid of needles which might prevent them from getting their Covid-19 vaccine.

“…therefore, among the methods that are being developed is administering the vaccine orally or using nasal spray,” he said in response to a supplementary question from Wong Kah Woh (Ipoh Timur MP) during a question and answer session at the Dewan Rakyat today.

Ahmad Amzad explained that PPVN would not be focusing solely on the production of the Covid-19 vaccine, but also on the development of other vaccines for humans.

He said currently, Malaysia only had the capacity to produce vaccines for animals.

On the local vaccine candidates, Ahmad Amzad said there were some that had passed the pre-clinical phase and would be tested on humans.

“InsyaAllah, based on the research that has been carried out, we will have our first Covid-19 vaccine candidate in 2024,” he said.

— Bernama

 

Top Picks

IMF revises up 2024 global growth forecast to 3.2 pct

Parents urged to lodge complaints if schools organise outdoor activities in hot weather

MAFS assures sufficient basic food supplies throughout Syawal